![Steven Harr](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Steven Harr
Oprichter bij
SANA BIOTECHNOLOGY, INC.
Vermogen: 30 M $ op 31-05-2026
Profiel
Steven D. Harr richtte Sana Biotechnology, Inc. en JW Therapeutics (Shanghai) Co., Ltd. op. Dr. Harr bekleedt de functie van President, Chief Executive Officer & Bestuurder bij Sana Biotechnology, Inc. en Penningmeester & Bestuurder bij X-Body, Inc. Hij zit ook in de raad van bestuur van JW Biotechnology (Shanghai) Co. Ltd. en Repertoire Immune Medicines, Inc. In het verleden bekleedde hij de functie van Research Analyst bij Morgan Stanley & Co. LLC, Chief Financial Officer & Head-Development bij Juno Therapeutics, Inc. en Bestuurder bij JW Therapeutics (Shanghai) Co., Ltd. Dr. Harr behaalde een bachelor aan het College of the Holy Cross (Massachusetts) en een doctoraat aan The Johns Hopkins University School of Medicine.
Bekende belangen in openbare bedrijven
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
| 30-03-2026 | 8.960.751 ( 3,46% ) | 30 M $ | 31-05-2026 |
Actieve functies van Steven Harr
| Bedrijven | Functie | Begin |
|---|---|---|
| SANA BIOTECHNOLOGY, INC. | Oprichter | 13-07-2018 |
JW Biotechnology (Shanghai) Co. Ltd. | Directeur/Bestuurslid | - |
X-Body, Inc.
 X-Body, Inc. BiotechnologyHealth Technology Provides biotechnological research services | Directeur/Bestuurslid | - |
Repertoire Immune Medicines, Inc.
 Repertoire Immune Medicines, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage biotechnology company that engages in immune medicines to prevent, treat and cure cancer | Directeur/Bestuurslid | 01-03-2020 |
Cobalt Biomedicine, Inc.
 Cobalt Biomedicine, Inc. Pharmaceuticals: MajorHealth Technology Engages in developing therapeutic based drugs | President | - |
Eerdere bekende functies van Steven Harr
| Bedrijven | Functie | Einde |
|---|---|---|
| LOXO ONCOLOGY INC | Directeur/Bestuurslid | 15-02-2019 |
JW Therapeutics (Shanghai) Co., Ltd.
 JW Therapeutics (Shanghai) Co., Ltd. BiotechnologyHealth Technology Develops cell-based immunotherapies to treat cancer | Oprichter | 25-09-2018 |
| JUNO THERAPEUTICS INC | Financieel Directeur/CFO | 01-03-2018 |
Morgan Stanley & Co. LLC
 Morgan Stanley & Co. LLC Investment Banks/BrokersFinance Provides brokerage services | Algemeen Directeur | 01-04-2014 |
| ░░ ░░░░░░░░ ░░░░░░░░░░░░ ░░░ ░░░ | ░░░░░░░░░ | - |
Opleiding van Steven Harr
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
86
Eerstegraads connecties
12
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 12 |
|---|---|
X-Body, Inc.
X-Body, Inc. BiotechnologyHealth Technology Provides biotechnological research services | Health Technology |
Morgan Stanley & Co. LLC
Morgan Stanley & Co. LLC Investment Banks/BrokersFinance Provides brokerage services | Finance |
College of the Holy Cross (Massachusetts)
 College of the Holy Cross (Massachusetts) Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Loxo Oncology, Inc.
 Loxo Oncology, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that develops medicine for cancer treatment | Health Technology |
The Johns Hopkins University School of Medicine
 The Johns Hopkins University School of Medicine Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Juno Therapeutics, Inc.
 Juno Therapeutics, Inc. BiotechnologyHealth Technology Operates as a biopharmaceutical company to treat cancer, HIV and cardiovascular diseases | Health Technology |
JW Biotechnology (Shanghai) Co. Ltd. | |
JW Therapeutics (Shanghai) Co., Ltd.
JW Therapeutics (Shanghai) Co., Ltd. BiotechnologyHealth Technology Develops cell-based immunotherapies to treat cancer | Health Technology |
JW (Cayman) Therapeutics Co. Ltd.
 JW (Cayman) Therapeutics Co. Ltd. BiotechnologyHealth Technology Operates as biotechnology company that develops and manufactures cell immunotherapy products | Health Technology |
Sana Biotechnology, Inc.
 Sana Biotechnology, Inc. BiotechnologyHealth Technology Operates as a biotechnological company which creates and delivers engineered cells as medicine for patients | Health Technology |
Cobalt Biomedicine, Inc.
Cobalt Biomedicine, Inc. Pharmaceuticals: MajorHealth Technology Engages in developing therapeutic based drugs | Health Technology |
Repertoire Immune Medicines, Inc.
Repertoire Immune Medicines, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage biotechnology company that engages in immune medicines to prevent, treat and cure cancer | Health Technology |
